Purchases and Sales Made in Q3 2022 in Acurx Pharmaceuticals, Inc. (ACXP)
This table provides information about the institutional ownership of Acurx Pharmaceuticals, Inc. (ACXP) during Q3 2022. The information is specifically focused on institutions that hold shares of Acurx Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
1.07MNew |
$3.2M - $5.1M
|
1.07M
$778K
|
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
64.7K+ 560.95% |
$194K - $309K
|
76.2K
$55.7K
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
47.4KNew |
$142K - $227K
|
47.4K
$34.6K
|
|
|
Nov 10, 2022
Q3 2022
|
Mariner, LLC
Overland Park, KS |
BUY
|
- |
16KNew |
$48K - $76.5K
|
16K
$11.7K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
3.05K+ 292.8% |
$9.14K - $14.6K
|
4.09K
$2.98K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.15K+ 65.36% |
$3.44K - $5.48K
|
2.9K
$2.12K
|
|
|
Nov 14, 2022
Q3 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
1K+ 9.09% |
$3K - $4.78K
|
12K
$8.76K
|
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
87New |
$261 - $416
|
87
$63.5
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
40+ 222.22% |
$120 - $191
|
58
$42.3
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-435- 2.72% |
$1.31K - $2.08K
|
15.5K
$11.4K
|